SecProbe.io

Stored correspondence activity detail
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

Correspondence Activity Detail

ENANTA PHARMACEUTICALS INC (ENTA) (CIK 0001177648) (ENTA)
Activity window: Oct. 25, 2025 to Oct. 24, 2026

Back View Correspondence Compare Probe Scores Download Probe Score CSV

Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.

Probe Score Breakdown

Current total
1.5 / 10
Correspondence-letter component
1.0
AI sentiment component
0.5
Keyword-match component
0.0
Signal-match component
0.0
Notable 8-K modifier
0.0

The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Feb. 17, 2026. These dates describe different events.

Correspondence Filings
1
Keyword Matches
0
Latest Activity
Feb. 17, 2026
Related 8-Ks
0

Matched Signals

No stored keyword or signal matches were recorded for this activity window.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Feb. 17, 2026 CORRESP Neutral/Informational Moderate Enanta Pharmaceuticals, Inc. has submitted a request for the acceleration of the effective date of its Registration Statement on Form S-3. The company aims for the registration to… Read Filing EDGAR
Feb. 17, 2026 UPLOAD Neutral/Informational Low The SEC has communicated to Enanta Pharmaceuticals Inc. that it will not review their registration statement filed on February 11, 2026. The letter emphasizes the company's respon… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in this activity window.